Investigational drug found useful to prevent transplant organ rejection
LEA29Y, a unique investigational treatment, can very soon be representing a novel and less toxic method to prevent transplanted kidney function and improve outcomes of patients, according to data presented at the American Transplant Congress.
More than twenty leading transplant centers in the U.S., Canada and Europe, including Emory University, participated for comparing LEA29Y, also known [...]


